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related to studies in LMICs and attempts to give the reasons 
for their limitations using epilepsy as an example. Results: 
Regional conditions and environmental factors must be giv-
en careful consideration in the research design because of 
the importance of understanding the challenges of living in 
these environments. There are further limitations to the suc-
cessful implementation of studies. Existing information on 
epilepsy is often not readily accessible; there is a lack of cen-
sus data, and migratory patterns into cities make enumera-
tion and sampling even more challenging. As there is usually 
no well-developed healthcare system a door-to-door screen-
ing process is often the only way to identify those with con-
vulsive epilepsy. The questionnaire and study design should 
preferably be adapted from standardized protocols, and pre-
tested and validated in local conditions. Conclusions: Sys-
tematic reviews and meta-analyses of studies in LMICs can 
provide data on the burden, risk factors, treatment and out-
come of epilepsy only if the primary studies used are prop-
erly conducted using uniform and comparable methodolo-
gy. The use of consistent replicable neuroepidemiological 
methods in primary studies and systematic reviews enable 
reduction of the treatment gap and better epilepsy care. 
 © 2013 S. Karger AG, Basel 
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 Abstract 
 Background: The majority of people with epilepsy (PWE) live 
in low- and middle-income countries (LMICs). However, they 
remain largely untreated and the bulk of resources are used 
to treat patients in the developed world. This disparity con-
stitutes a challenge for neuroepidemiological studies on a 
global scale. In the past, several studies have focused on di-
verse populations in disparate countries at various periods of 
time and for particular purposes. The specificity of different 
contexts and circumstances makes it difficult to analyse PWE 
as a group either qualitatively or quantitatively. Such meth-
odological limitations are further complicated by a lack of lo-
gistical support. There is a lack of interest in conducting stud-
ies, which results in inadequate funding and, in addition, 
there is the considerable challenge of publishing research 
reports from LMICs in peer-reviewed international journals. 
Methods: This paper focuses on methodological problems 
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 Introduction 
 The majority of resources utilized in the treatment of 
epilepsy worldwide is accounted for by high-income 
countries. However, the majority of people with epilepsy 
(PWE) live in low- and middle-income countries (LMICs), 
most of them in the tropics. Therefore, most PWE do not 
receive appropriate treatment, which is known as the 
treatment gap  [1] . Meinardi et al.  [2] identified the fol-
lowing factors as being mainly responsible for the treat-
ment gap: inadequate case ascertainment in a population, 
failure to diagnose epilepsy, and lack of appropriate treat-
ment of epilepsy, which could include medical, surgical 
or sociocultural intervention. In addition, the treatment 
gap can also be due to lack of treatment of an underlying 
cause of epilepsy and failure to continue treatment once 
started. The latter is often referred to as secondary treat-
ment gap.
 Unfortunately there are only a few incidence studies of 
epilepsy in LMICs, there are several prevalence studies 
with different study designs, usually identifying convul-
sive epilepsy in which the aetiology is unknown, hardly 
any natural history studies, few unbiased case-control 
studies, and a number of studies mentioning the size of 
treatment gap but few which analyse it.
 There are a few systematic reviews and meta-analyses 
concerning some of the above issues. Most of them have 
some or all of the following problems: insufficient scru-
tiny of the existing literature, methodological differences, 
differences in case ascertainment, differing definitions of 
epilepsy and active epilepsy, lack of age-adjustment, use 
of populations which may not be representative of the 
general population. Judgment is needed on the part of the 
person carrying out the meta-analysis about the weight-
ing given to every study included. Weighting requires as-
sessment of methodological quality, i.e. the effort made to 
minimize bias or systematic error, precision of each study 
as expressed by the width of the 95% confidence interval, 
and the external validity of the study which is the extent 
to which one may generalize its results  [3] . These meta-
analyses of incidence studies  [4] , prevalence studies  [5] 
and treatment gap in epilepsy  [6, 7] have demonstrated a 
high degree of unexplained heterogeneity. This is possi-
bly due to the methodological differences and judgments 
about which studies to include or exclude  [8] . Problems 
with meta-analyses are greatest when there are few pri-
mary studies, as with incidence studies, and where there 
is wide variation in rates  [4, 9] .
 Consistently applicable epidemiologic methods are 
needed in LMICs to generate comparable data on the bur-
den of epilepsy, outcome of interventions, risk factors and 
treatment. Systematic reviews and meta-analyses using 
such well-executed primary studies would be of use to all 
those involved in the care of epilepsy.
 Regional Difficulties 
 There are various difficulties in the use of globally ap-
plicable techniques in LMICs. The purpose of this paper 
is to highlight such fundamental problems and challenges.
 LMICs display certain common characteristics. Often, 
the environment is marked by a specific tropical, equato-
rial or subtropical climate. There is poor sanitation, which 
promotes the spread of infections. Environmental toxins 
are common and people are malnourished. Individual, 
population-based, cross-sectional and case control stud-
ies of active convulsive epilepsy were carried out in five 
centres in sub-Saharan Africa  [10] . In order to reduce 
heterogeneity of findings, the authors used the same 
methods and definitions between regions. Interestingly, 
they found that heterogeneity could be accounted for by 
markers of birth trauma, exposure to a range of parasites 
and other factors including malnutrition and ingestion of 
cassava  [10] . The relationship between epilepsy and mal-
nourishment is a complicated one. In order to ascertain 
which came first, one would need a long-term cohort 
study of people with malnutrition or with epilepsy  [11] . 
Such studies would be very difficult to conduct in LMICs.
 Scarce resources also lead to poor access to care and 
greater inequality in access. Meta-analysis of prevalent 
studies of active epilepsy and lifetime epilepsy through-
out the world found the prevalence of epilepsy was high-
est in rural areas of LMIC, lower in urban parts of LMIC 
and lowest in high-income countries  [5] . The authors felt 
that access to healthcare was an important determinant 
of these results.
 There is inadequate public health and the health sys-
tems are also inadequate. There are many specific socio-
cultural characteristics that may by themselves be risk 
factors for neurological disease. The population is young, 
with a low life expectancy compounded by the HIV/AIDS 
pandemic. There is currently rapid and uncontrolled ur-
ban and suburban growth, again creating a mismatch in 
healthcare provision. Political factors, i.e. unstable gov-
ernments, multiple levels of decision making and the low 
priority given to health programs, worsen the situation. 
In particular, curative and preventive neurological health 
services are often very weak or lacking altogether.
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 A recent study of treatment gap in Kilifi, Kenya, found 
a treatment gap of 62.4% which was attributable to a 
number of factors including traditional beliefs, negative 
attitudes, chronic epilepsy, focal seizures, learning diffi-
culties, living far from health facilities and having to pay 
for treatment  [12] . It is important for any investigator to 
assess this ‘big picture’, not only from the point of view of 
designing a good study, but also to better place epilepsy 
in the context of local difficulties.
 Carrying out epidemiological research in these settings 
poses difficulties for a variety of reasons – methodological, 
logistic, political, economic, ethical and often the low-per-
ceived value of such work  [13] . Also, the enormous diver-
sity of such populations makes it difficult to generalize.
 What Is Known? 
 As a first step, it is essential to ascertain what work has 
already been accomplished in the area of interest. The 
primary difficulty is identifying what is known about ep-
ilepsy and PWE in the region to be studied.
 Obtaining existing information on epilepsy in a new 
region can be challenging. Published studies are scarce in 
these areas, and it is often difficult to obtain historical in-
formation. Those studies that do exist are frequently dif-
ficult to compare because their methodologies are not 
standardized and sometimes there is duplication  [14] .
 An extensive literature search can provide unexpected 
historical data. For example, the authors in a study about 
epilepsy in Lao People’s Democratic Republic (Lao PDR) 
initially found no data in the literature. However, consul-
tations with relevant experts and health authorities re-
vealed that an investigation had been performed on the 
state of mental illness in Lao PDR by the Ministry of 
Health years before, and that the report of the survey 
mentioned a number of data on epilepsy  [15] . Therefore, 
activity reports of ministries and various organizations 
are more likely to provide results of previous studies than 
the search in peer-reviewed published literature.
 Studies are not necessarily indexed in major interna-
tional bibliographic databases, and it is necessary to 
search for national publications or ‘grey’ literature. Many 
theses and less formal accounts have described neurolog-
ical problems in the tropics. There is a virtual library of 
African neurology on the website of the Institute of Neu-
rological Epidemiology and Tropical Neurology (www-
ient.unilim.fr). Another database is the Wan Fang Data-
base of English and Chinese online journals published in 
mainland China (www.wanfangdata.com).
 Methodology 
 Identifying an Area and Population 
 Methodological standards are the same everywhere, 
reflecting the universal need to collect data on which to 
base a detailed protocol. This process may be difficult be-
cause of a lack of accurate demographic data, particularly 
census information. Rural activities, scattered homes in 
rural areas and lack of correct addresses will impair the 
validity of the study  [13] . There is also often a lack of de-
tailed cartographic data. It is absolutely essential to in-
volve key people in the country and in the area of interest 
of the study, developing a true partnership, a real co-op-
eration in the sense of a joint operation. Repeated visits 
to the area targeted by the survey can be useful, as can 
pilot studies. One should also know how to use tools such 
as a global positioning system (GPS) and remote sensing 
from satellites which may generate useful data from cur-
rent population maps. This technology has become rela-
tively accessible and can provide a sufficiently detailed 
up-to-date map of the survey area. Such maps are indis-
pensable in areas where maps do not exist and where 
there are frequent population movements.
 Other methodological difficulties must be taken into 
account. Geographical limits alone are insufficient to de-
fine a population. Population censuses are rare and often 
not confined to a specific period. There are many causes 
for populations moving: work, sociopolitical factors or 
war must be considered over a long period. In LMICs, it 
is common for people to migrate from villages to cities 
and special economic zones in search of work. Migration 
may be permanent or show a seasonal pattern. When peo-
ple come into cities as day labour because agricultural ac-
tivities are in abeyance, these people often end up living 
in urban settlements, but retain their original social orga-
nization and cultural customs which may be distinctly 
different from the surrounding population. The stable in-
frastructure of the city may not necessarily be able to pro-
vide access to them for required services (www.unfpa.
org/6billion/populationissues/migration.htm). It is im-
portant to consider such communities in an epidemio-
logic survey as they are at higher risk for severe health 
outcomes – although identifying and following them is a 
particular challenge.
 Census 
 When a census has not previously been carried out, it 
can be done either before or during the main study. Two 
strategies can be adopted. One can either carry out a 
door-to-door survey of an entire community or village or 
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use a sampling approach. Amongst the first such door-to-
door screening protocols for neurological diseases were 
designed in the 1980s by the World Health Organization 
 [16] and the National Institutes of Health  [17] . This pro-
tocol was used to carry out community-based surveys in 
China, Nigeria and India  [18–20] .
 Alternatively, a specific sampling mode can be applied, 
such as a cluster sampling technique. It does not require 
prior enumeration of each person, but is based on a list of 
‘clusters’. In many LMICs this approach makes possible 
the estimation of the burden of epilepsy more rapidly in 
a given setting at a much lower cost. Most frequently, vil-
lages are taken as clusters  [21] . They are selected by lot to 
have all their inhabitants included in the survey. Thus, 
cluster surveys provide a geographical grouping of vil-
lages on which to focus the investigation. However, it is a 
challenge to be certain that all the inhabitants of a village 
have been included. Also, cluster surveys require higher 
sample sizes than conventional surveys as the analysis 
must take the clusters into account. WHO simulations 
indicated that double the study population is required. 
Cluster sampling can also be used in urban areas, using 
for example districts or parts of the town as clusters, but 
this practice could lead to biases since the clusters do not 
necessarily represent correctly the whole population 
since people could be diversely dispersed in the town ac-
cording to their ethnicity, dialect, or whether or not they 
live in urban slums. Other more complex sampling meth-
ods may be used  [22] . The awareness of local authorities 
and the local population is even more important, and the 
protocol should include procedures which fully explain 
the course of events.
 Screening 
 Identification of cases may also cause methodological 
challenges. Some disorders carry an important stigma. 
Epilepsy may be seen as associated with possession, or as 
a contagious disease  [23] . This can result in the conceal-
ment of cases, even during door-to-door interviews, 
which remain the gold-standard neuroepidemiological 
approach in LMICs. Normally, concealing epilepsy is 
more difficult in rural areas than in the city. Another pos-
sibility is that people with focal or absence seizures may 
not realize that their problem is actually epilepsy, particu-
larly if they have more traditional views of the illness.
 In many studies, the head of the household is targeted 
and is interviewed on behalf of the entire household. A 
study in Mexico found that interviewing heads of house-
holds was inadequate and considerably underestimated 
the prevalence of epilepsy  [24] . Multiple sources of infor-
mation may be useful to complement door-to-door sur-
veys as was shown in the Benin survey  [25] . Information 
obtained door-to-door was supplemented with medical 
data from hospital records, clinics, pharmacies, etc. and 
by non-medical information from key informants, village 
chiefs, traditional healers and teachers. Using multiple 
sources of information allows the application of the cap-
ture-recapture method which is a statistical method that 
is used to calculate corrected prevalence rates taking into 
account information from three sources: the head of the 
household, medical data and non-medical information 
 [25] .
 Rescreening a sample of a population will also help 
identify PWE missed in the initial survey. False-negative 
rates can be calculated to give a ‘maximum estimated 
prevalence’  [26] .
 The same epidemiological assessment tools and defi-
nitions should be used throughout, despite diverse eth-
nicity, the existence of many different dialects, percep-
tions and socio-cultural backgrounds. Hence, interview-
ers and interpreters where necessary need substantial 
training to ensure that the questions used can be under-
stood by the different population segments and respond-
ed to in the same manner. In addition, quality control 
measures must be put in place to ensure the consistency 
of the procedures throughout the data collection period. 
Questionnaires should be clearly adapted, validated, 
translated into the dialects used, and retranslated back 
into the language of origin to check their comprehensi-
bility  [17, 20, 27, 28] . In LMICs the screening question-
naire is designed to identify convulsive seizures only. 
Hence, other kinds of epilepsy are omitted in most such 
studies. The inclusion of questions regarding non-con-
vulsive seizures increases sensitivity, but decreases spec-
ificity of the questionnaire, overburdening the few avail-
able study neurologists. It is particularly important that 
questionnaires are pretested for specificity and sensitiv-
ity in the same community prior to carrying out the pilot 
survey. To avoid prejudicing the actual sample popula-
tion, the testing of the questionnaire should not be done 
with people actually residing in the area to be surveyed, 
nor should the pilot study be carried out among people 
to be included in the main study  [17] . To test the ques-
tionnaire, it is necessary to have an adequate sample of 
people with and without epilepsy. Such testing is usually 
carried out in the setting of a hospital or clinic. However, 
it is difficult to ensure that the community on whom the 
questionnaire is being tested is similar to that in a distant 
rural area.
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 New Technologies 
 Today, new technologies offer tremendous opportuni-
ties to facilitate data collection, manage and analyse it, 
and communicate results. Electronic data collection is 
about to replace paper-based surveys. It has several ad-
vantages. Devices such as mobile phones, using short 
message service (SMS), have effectively been used in 
LMICs in collecting data and communicating findings in 
disease control programs  [29] . However, sending large, 
complex amounts of data by SMS is difficult. Personal 
data assistants (PDAs) allow the collection of more com-
plex data. The development of Android (Google Inc.) 
platform applications has led to so-called ‘smart’ devices 
(primarily touch-screen mobile devices, such as smart 
phones and tablet computers) with a multitude of appli-
cations. Many devices offer the additional advantage of 
having built-in GPS which automatically captures geo-
graphic co-ordinates from external GPS devices. The ear-
lier process of transcribing co-ordinates to paper from 
external GPS devices is circumvented, thus minimizing 
transcription errors in the field. A recent comparison of 
the smart device versus the paper-based survey showed 
that the smart device collected data of similar quality at a 
much lower cost  [30] . Therefore, an evaluation of PDA 
devices in surveys of PWE would be most welcome. The 
perception of PWE to these devices should be taken into 
consideration.
 Diagnosis 
 Methodological difficulties may also relate to diagno-
sis which is mainly clinical. An eye-witness account is 
essential. A cell phone can be used by the eye witness to 
record the seizure on video. Patients identified positive 
on the screening questionnaire should be seen by a clini-
cian as soon as possible. This is often difficult for logistic 
reasons. Also, ideally, the clinician should be a neurolo-
gist with experience in epilepsy as it is important to make 
a correct diagnosis and to document seizure semiology 
in order to rule out non-epileptic events and to distin-
guish between focal and generalized seizures. Specialists 
trained in neurology or epidemiology are scarce, in par-
ticular in LMICs where they would be particularly im-
portant.
 Electroencephalography (EEG) is necessary to identify 
absence seizures and to define a specific syndrome. There 
is often a shortage of EEG equipment and, more impor-
tantly, of appropriately trained people to perform and in-
terpret an EEG in the field. Video EEG monitoring is use-
ful for electrophysiological and clinical co-relation, but is 
rarely available and affordable. Both computed tomogra-
phy scans and magnetic resonance imaging are rarely 
available facilities and require substantial resources of 
health providers and patients. If available, they are fre-
quently undergoing maintenance or have broken down. 
Lack of clinical data, EEG and imaging data results in dif-
ficulty in classifying seizures and epilepsy.
 Definitions 
 The diagnosis of epilepsy should be made using uni-
form guidelines. A 1993 International League Against 
Epilepsy (ILAE) commission required at least 2 unpro-
voked seizures more than 24 h apart for a definition of 
epilepsy. Febrile seizures, acute symptomatic seizures, 
status epilepticus and multiple seizures within 24 h were 
thereby excluded  [31] . Furthermore, without neuroim-
aging it is impossible to exclude certain kinds of acute 
symptomatic seizures such as those due to a dying neu-
rocysticercal granuloma. Hospital-based studies suggest 
that neurocysticercosis is a major cause of seizures and 
epilepsy in developing countries  [32] . It is important to 
distinguish between acute symptomatic seizures caused 
by an active neurocysticercal lesion and unprovoked sei-
zures due to a resolved brain lesion. Most patients who 
have recovered from neurocysticercosis do not develop 
epilepsy later  [33] . Correspondingly, those studies which 
fail to exclude patients who have had acute symptomatic 
seizures due to neurocysticercosis show more epilepsy 
due to neurocysticercosis than studies which have ex-
cluded these patients  [34] . A 2005 definition of epilepsy 
by ILAE and the International Bureau of Epilepsy (IBE) 
stated that epilepsy is a cerebral disorder manifesting 
with a single seizure and having an ‘enduring predisposi-
tion to generate epileptic seizures’ and with ‘neurobio-
logic, cognitive, psychological and social consequences’ 
 [35] . While this definition might come closer to the true 
nature of the disorder, it is much harder to translate it 
into a practical tool to be applied in studies in settings 
where predominantly health workers with little training 
are involved in diagnosing, reporting and treating pa-
tients. A further problem is the new and different ILAE 
classification of epilepsy by aetiology. The terms idio-
pathic, symptomatic and cryptogenic have been replaced 
by genetic, structural/metabolic and unknown categories 
 [36, 37] . Changing definitions of epilepsy causes prob-
lems in comparing results both within and among set-
tings and countries.
 It is also important to distinguish between lifetime ep-
ilepsy and active epilepsy. Unfortunately, active epilepsy 
has been defined in different ways – using a cut-off of the 
last seizure occurring 1, 2 or 5 years prior to identifica-
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tion  [37, 38] . One reason given for using a shorter dura-
tion is that people may have problems recalling past sei-
zures. Differing definitions of active epilepsy lead to dif-
ferent estimates of burden of epilepsy and treatment gap 
 [6, 32] .
 Determining the Age of Study Participants 
 An additional problem in some remote rural areas of 
LMICs is the difficulty in determining the precise age of 
subjects, particularly if they are older. Indeed, official pa-
pers are often missing and some may be falsified for vari-
ous reasons. The knowledge of age is required to provide 
age-specific/age-adjusted rates. Without such data, it is 
not possible to accurately compare rates between the usu-
ally young and older populations of LMICs. Different 
methods of age estimation have been developed and im-
plemented, including the use of historical events to avoid 
such difficulties  [39] . Age of onset of epilepsy is also in-
adequately recalled and even sometimes concealed by 
married women who did not disclose their epilepsy at the 
time of marriage.
 Age of onset of epilepsy is an important element to 
classifying seizures and exploring aetiology. Without 
knowledge of age at first seizure, duration in years be-
tween first and second seizure and age at diagnosis, it is 
difficult to identify incident cases. Case control and out-
come studies should be carried out on incident rather 
than prevalent cases. If prevalent cases are used, it is not 
clear whether putative risk factors precede or follow on-
set of epilepsy. Also, prevalent cases represent a popula-
tion of those who survive and continue to have seizures, 
thus resulting in an incidence-prevalence discrepancy. 
This gap represents those who have had epilepsy but who 
have died or whose seizures have remitted. The inci-
dence-prevalence gap is much higher in Latin America 
and Africa than in Asia and developed countries  [14, 40, 
41] . There are few studies of the natural history of epi-
lepsy in LMICs  [42] . Such studies are needed to assess 
prognosis, i.e. seizure remission and mortality among 
PWE. Long-term outcome studies of PWE are difficult 
because people are lost to follow-up. The effect of treat-
ment is difficult to assess because compliance is uncer-
tain. Mbuba et al.  [12] found that the sensitivity and the 
specificity of self-reported adherence was poor. The lack 
of death certificate data and autopsies make cause of 
death difficult to ascertain and verbal autopsies have to 
be relied upon. A review of epilepsy and mortality in Af-
rica found one study which reported a 6-fold increase in 
mortality in PWE  [43] and the cause of death was largely 
epilepsy related, unlike the situation in high-income 
countries where epilepsy-related deaths are uncommon. 
More outcome studies are imperative, particularly using 
incidence rather than prevalence cohorts.
 Socioeconomic Status 
 As socioeconomic status is known to be associated 
with the risk and consequences of epilepsy, it is useful to 
have a uniformly applicable measure of it  [44, 45] . This 
would facilitate comparisons of risks and outcomes be-
tween populations. In LMICs such as India, socioeco-
nomic status can be considered in two major categories: 
(i) background status and (ii) current status [Dr. V. Patel, 
pers. commun.].
 Background Socioeconomic Status 
 In LMICs such as India, educational status and an in-
dex of assets held are easier and more reliable to assess 
than income. Unlike the situation in high-income coun-
tries, income is difficult to assess due to the fact that the 
vast majority of people work in the unorganized or infor-
mal sector. Also, in LMICs, there is an unwillingness
to divulge personal information to strangers. In LMICs 
where basic education is more uniformly available, in-
come becomes a more important criterion. The back-
ground socioeconomic status probably influences the risk 
of epilepsy, for example through inequitable access to 
quality maternal and child healthcare.
 Current Socioeconomic Status 
 Current status is measured in LMICs by factors which 
reflect recent economic distress, such as indebtedness and 
hunger, and is probably a better index of the consequenc-
es of epilepsy. The distinction between background and 
current socioeconomic status is not as clear as it appears, 
since assets may be sold to meet current needs. 
 Both these measures need to be uniformly assessed, 
using standardized and validated methods. In a recent
review of the relationship between poverty and mental 
health in LMICs, it was found that only 7% of indicators 
of poverty were measured by standardized validated 
methods  [46] . Asset-based assessment of socioeconomic 
status is widely used in researching neglected tropical dis-
eases but less commonly in epilepsy  [12] . Its advantage is 
in allowing comparisons across large areas.
 Sociocultural Factors 
 Unlike the situation with socioeconomic status, which 
can be related to both cause and effect of epilepsy, socio-
cultural factors mainly influence the prognosis and out-
come of epilepsy. Beliefs and perceptions influence help-
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seeking in several ways, including recognition of a sei-
zure disorder, the possibility that medical treatment 
exists, and the type of treatment sought. Projects aimed 
both at research into these areas and at training staff 
would be useful. These should preferably be multidisci-
plinary and involve both the humanities and social sci-
ences.
 Other Problems 
 Logistics 
 The logistics of providing consumables and medical 
equipment cause problems. These include transport 
across insecure regions and severe climatic conditions 
which make maintaining equipment difficult.
 Motivation 
 In LMICs, lack of interest in neuroepidemiological 
studies leads to insufficient knowledge of the extent and 
impact of epilepsy and hence low priority at all levels of 
policy making and public health. Many decision-making 
bodies encounter some difficulty in deciding on resource 
allocation  [47] . At all levels of government – national, re-
gional, district and communal – it is necessary to obtain 
agreement on those surveys that have been conducted. 
Ideally, there should be an integrated plan to improve 
knowledge of neurological epidemiology, which should 
then be incorporated into the national health pro-
grammes.
 Funding 
 Providing immediate and long-term funding is a ma-
jor drawback. It is important that requests for funding for 
high-quality projects be submitted to foundations, which 
can be appropriate sponsors. Internationally provided 
money usually targets tuberculosis, malaria and HIV. 
Other tropical diseases are beginning to receive increas-
ing attention. These are the neglected tropical diseases 
which have been inadequately addressed in LMICs. They 
might have a considerable connection with epilepsy or 
other neurological disorders. It is imperative to organize 
a real curative service to the screened population in paral-
lel with epidemiological investigations.
 Ethics 
 Ethical questions are extremely sensitive. There are 
still far too few independent ethics committees in re-
source-poor countries. Where no committee exists, obvi-
ously health authorities should act, but they are less inde-
pendent than a designated body. In addition, signed in-
formed consent is often too complicated to obtain, and it 
is necessary to establish simple consent protocols that the 
population can truly understand. Written and signed 
consent may be impossible because of illiteracy, but writ-
ten evidence of comprehension and oral consent can be 
obtained via a witness. The risk/benefit ratio should be 
accurately evaluated. Finally, all the difficulties related to 
the appreciation of neuroepidemiological work in tropi-
cal countries should not be overlooked even if, overall, 
they diminish over time.
 Quality of Research 
 These methodological and logistical difficulties result 
in the implementation of studies of relatively modest 
quality. Samples may be small, leading to a lack of power. 
The accuracy of diagnosis may be lower as equipment is 
not available. Hence, studies are often published in lo-
cal journals, which are often not indexed in major inter-
national databases. In the major international journals,
it is sometimes more difficult to publish a study from
an LMIC than similar work from the developed world. 
However, it is still quite possible if the study is truly orig-
inal and adequately targeted and if the quality of the 
translation into English (if, of course, the journal is in 
English) has been verified by a professional translator. It 
is best to avoid multiple publications using the same data 
from a single study.
 Conclusion 
 Many specific methodological difficulties face those 
conducting neuroepidemiological studies in LMICs, 
most of them tropical. Nevertheless, the concepts and 
methods applied must be the same as those used globally, 
even if it is clear that their translation into practice may 
differ. Neuroepidemiological research in these countries 
is difficult, but feasible, and extremely useful to provide 
decision-makers with the knowledge they need to allocate 
limited resources in the best way possible in order to re-
duce the treatment gap. Genuine co-operation at all levels 
is absolutely necessary if such research is to be conduct-
ed under appropriate conditions. The survey protocol 
should be particularly detailed and thorough. Specific ep-
idemiological methodologies may be useful, and the col-
lection of data must be standardized. Neuroepidemiolog-
ical research therefore requires careful organization and 
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the development of solutions specific to LMICs. Current-
ly, 90% of health research addresses 10% of the world’s 
health problems of the global population. This mismatch 
should not continue. Increased emphasis on neuroepide-
miological studies in LMICs and systematic reviews and 
meta-analyses of such studies have a role to play in re-
establishing a balance.
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